Danaher Corporation (BVMF:DHER34)

Market Cap	794.27B
Revenue (ttm)	131.55B
Net Income (ttm)	18.70B
Shares Out	n/a
EPS (ttm)	25.82
PE Ratio	42.48
Forward PE	24.79
Dividend	0.17 (0.42%)
Ex-Dividend Date	Sep 25, 2025

Volume	365
Average Volume	2,057
Open	39.70
Previous Close	39.14
Day's Range	39.69 - 39.70
52-Week Range	33.66 - 56.55
Beta	0.80
RSI	56.47
Earnings Date	Oct 21, 2025

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1969
• Employees: 63,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: DHER34

Financial Performance

In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.

Financial numbers in USD